Sexually Transmitted Diseases (STD) Testing Market Report 2026

Sexually Transmitted Diseases (STD) Testing Market Overview

• Sexually Transmitted Diseases (STD) Testing market size has reached to $8.78 billion in 2025 • Expected to grow to $13.05 billion in 2030 at a compound annual growth rate (CAGR) of 8.2% • Growth Driver: Rising HIV Prevalence Fueling The Growth Of The Market Due To Increasing Awareness And Early Detection Needs • Market Trend: Advancements In Home-Based Syphilis And HIV Testing Kits Enhance Accessibility And Accuracy • North America was the largest region in 2025 and Europe is the fastest growing region.

What Is Covered Under Sexually Transmitted Diseases (STD) Testing Market?

Sexually transmitted disease (STD) testing refers to the medical process of identifying infections that are primarily spread through sexual contact. It plays a critical role in early diagnosis, helping to prevent complications and limit the spread of infections through timely treatment and counseling. Regular screening is often recommended for individuals who are sexually active, as many infections may not show immediate symptoms but can still be transmitted to others. The main products of sexually transmitted disease (STD) testing include instruments and services, consumables, and software. Instruments and services refer to the diagnostic equipment and support activities used in clinical settings to perform medical testing. It uses both immunoassay and molecular diagnostics technologies and can be performed using blood samples, urine samples, swabs, semen samples, and others. It is used for various disease types, including chlamydia, gonorrhea, syphilis, HIV or AIDS, and herpes simplex virus (HSV), by several end users, such as individuals, healthcare providers, health insurance providers, government health agencies, NGOs, and community health organizations.

What Is The Sexually Transmitted Diseases (STD) Testing Market Growth Forecast?

The sexually transmitted diseases (std) testing market size is expected to see strong growth in the next few years. It will grow to $13.05 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to increasing demand for confidential testing solutions, rising investments in molecular diagnostics, expansion of telehealth-enabled testing, growing focus on preventive healthcare, increasing government initiatives for disease control. Major trends in the forecast period include increasing adoption of at-home std testing kits, rising use of molecular diagnostic technologies, growing integration of digital health platforms, expansion of rapid point-of-care testing, enhanced focus on early disease detection.

Global Sexually Transmitted Diseases (STD) Testing Market Segmentation

1) By Product: Instruments And Services, Consumables, Software 2) By Technology: Immunoassay, Molecular Diagnostics 3) By Sample Type: Blood Samples, Urine Samples, Swabs, Semen Samples, Other Sample Types 4) By Disease Type: Chlamydia, Gonorrhea, Syphilis, HIV Or AIDS, Herpes Simplex Virus (HSV) 5) By End User: Individuals, Healthcare Providers, Diagnostic Laboratories, Govement Health Agencies, NGOs And Community Health Organizations Subsegments: 1) By Instruments And Services: Diagnostic Instruments, Testing Services 2) By Consumables: Reagents And Kits, Specimen Collection Devices, Slides, Tubes 3) By Software: Laboratory Information Management Systems (LIMS), Electronic Health Records (EHR) Integration Tools, Data Analysis And Reporting Tools, Patient Management Software

What Is The Driver Of The Sexually Transmitted Diseases (STD) Testing Market?

The rising prevalence of HIV is anticipated to propel the growth of the sexually transmitted diseases (STD) testing market in the coming years. HIV is a virus that weakens the immune system by attacking and destroying crucial white blood cells, making the body more vulnerable to infections and diseases. HIV cases are rising due to declining awareness and prevention efforts, which have resulted in more people engaging in risky behaviors, such as unprotected sex, and fewer individuals getting tested, especially among the youth. The rise in HIV cases supports the demand for sexually transmitted disease (STD) testing as it heightens public and healthcare awareness, prompting more individuals to seek comprehensive testing to detect infections early and prevent further transmission. For instance, in July 2024, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS), a Switzerland-based government body, around 1.3 million people were newly infected with HIV in 2023, which is nearly three times higher than the 2025 target of under 370,000 cases. Therefore, the rising prevalence of HIV will boost the growth of the sexually transmitted diseases (STD) testing industry.

Key Players In The Global Sexually Transmitted Diseases (STD) Testing Market

Major companies operating in the sexually transmitted diseases (std) testing market are F Hoffmann La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Siemens Healthineers AG, Becton Dickinson And Co., Hologic Inc., QuidelOrtho Corp., Bio-Rad Laboratories Inc., Cepheid, OraSure Technologies Inc., Meridian Bioscience Inc., Sekisui Diagnostics Ltd., Trinity Biotech Plc, Chembio Diagnostics Inc., Operon SA, Jal Medical Pte. Ltd., Anatolia Geneworks, CLIAwaived Inc., Avecon Healthcare Pvt. Ltd., AEHEALTH LIMITED.

Global Sexually Transmitted Diseases (STD) Testing Market Trends and Insights

Major companies operating in the sexually transmitted diseases (STD) testing market are focusing on developing advanced solutions, such as syphilis testing kits, to make testing accessible to a wider population. Syphilis testing kits are diagnostic tools used to detect the presence of the Treponema pallidum bacteria, which causes syphilis, through blood samples or other bodily fluids for timely diagnosis and treatment. For instance, in August 2023, iHealth Labs Inc., a US-based medical device company, launched the CheckMeSafe home collection kit for HIV and syphilis testing. The FDA-approved iHealth CheckMeSafe Home Collection kit allows individuals aged 18 and older to collect blood samples for HIV (I, II, P24 antigen) and syphilis testing from the comfort and privacy of their own home. Users can mail their samples to the lab using a prepaid overnight label and receive confidential, reliable results in as little as two days. The kit provides highly accurate results, with sensitivity rates of up to 99.9% for HIV and 99.5% for syphilis. All samples are analyzed in a CLIA-certified and CAP-accredited laboratory, ensuring compliance with strict federal and state quality standards through regular inspections.

What Are Latest Mergers And Acquisitions In The Sexually Transmitted Diseases (STD) Testing Market?

In December 2023, imaware, a US-based company that offers at-home health testing kits, acquired binx health’s at-home consumer testing business. As a result of the acquisition, imaware will strengthen its presence in the expanding home-health testing market and increase its enterprise client base. Meanwhile, binx health will continue to operate and grow its point-of-care molecular diagnostics division, which is not part of the deal. binx health is a US-based provider of sexually transmitted disease (STD) testing solutions.

Regional Outlook

North America was the largest region in the sexually transmitted diseases (STD) testing market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Sexually Transmitted Diseases (STD) Testing Market?

The sexually transmitted diseases (STD) testing market consists of revenues earned by entities by providing services such as confidential testing, walk-in clinic testing, online test ordering, telehealth consultations, and partner notification services. The market value includes the value of related goods sold by the service provider or included within the service offering. The sexually transmitted diseases (STD) testing market also includes sales of at-home test kits, multi-infection panel kits, blood collection devices, biohazard specimen bags, and portable sample storage containers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Sexually Transmitted Diseases (STD) Testing Market Report 2026?

The sexually transmitted diseases (std) testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the sexually transmitted diseases (std) testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.